Accelerate Diagnostics, Inc - 00430H102

Sector: Technology · Industry: Laboratory Analytical Instruments
Website: No information yet · Social: No information yet

Company profile

Description is not available for this instrument yet.

Quarter snapshot

Latest / Compare
Q2 2023 · Q1 2023
Value (USD)
Total reported value ($000)
$4.749M
QoQ value delta ($000)
+$64K (+1.37%)
Implied price effect (QoQ)
+15.58%
Shares
Total shares
5,885,056
QoQ shares delta
-825,042 (-12.3%)
Total shares held by funds (by quarter)

Top holders (Q2 2023)

Top 25 only Full list
Early Q2 2025 data: only 1 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
VANGUARD GROUP INC 2,347 2,898,363 0.0%
Alyeska Investment Group, L.P. 1,003 1,238,986 0.01%
GEODE CAPITAL MANAGEMENT, LLC 531 655,906 0.0%
STATE STREET CORP 199 246,757 0.0%
Allworth Financial LP 124 154,000 0.0%
NORTHERN TRUST CORP 120 148,865 0.0%
MILLENNIUM MANAGEMENT LLC 99 123,141 0.0%
ROYAL BANK OF CANADA 62 76,924 0.0%
UBS Group AG 41 50,811 0.0%
BANK OF AMERICA CORP /DE/ 33 41,588 0.0%
CIBC Private Wealth Group, LLC 31 39,424 0.0%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 24 30,507 0.06%
Baird Financial Group, Inc. 24 30,029 0.0%
Mariner, LLC 23 29,065 0.0%
MORGAN STANLEY 18 22,322 0.0%
GLENMEDE TRUST CO NA 14 20,000 0.0%
Bank of New York Mellon Corp 11 14,382 0.0%
StoneX Group Inc. 9 11,940 0.01%
CITADEL ADVISORS LLC 9 12,200 0.0%
STIFEL FINANCIAL CORP 8 10,000 0.0%
SRS Capital Advisors, Inc. 8 10,000 0.0%
Steward Partners Investment Advisory, LLC 3 4,100 0.0%
BNP PARIBAS ARBITRAGE, SNC 2 3,102 0.0%
WELLS FARGO & COMPANY/MN 1 2,359 0.0%
GROUP ONE TRADING, L.P. 1 2,455 0.0%